Hussman Strategic Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,336	Closed	-$803K	–	339
2021 Q4	$803K	Buy	+8,336	New	+$803K	0.18%	183